Early switch in tyrosine kinase inhibitor therapy for patients with chronic myeloid leukemia: An emerging clinical question
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference71 articles.
1. Effect of nilotinib (NIL) on molecular response in chronic myelogenous leukemia – chronic phase (CML-CP) patients (pts) with a suboptimal molecular response to imatinib (IM)—ENABL study update;Ailawadhi;Blood,2011
2. Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase;Alvarado;Cancer,2009
3. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet;Baccarani;J. Clin. Oncol.,2009
4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013
5. Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia;Bixby;Leukemia,2011
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC;Expert Review of Anticancer Therapy;2024-04-21
2. Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review;Translational Lung Cancer Research;2023-03
3. Combined Therapy of ATRA and Imatinib Mesylate Decreases BCR-ABL and ABCB1/MDR1 Expression Through Cellular Differentiation in a Chronic Myeloid Leukemia Model;In Vivo;2021
4. The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice;Frontiers in Oncology;2019-06-26
5. Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy;Leukemia Research;2018-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3